Research and Markets: Pyelonephritis Pipeline Review, H2 2015
September 04 2015 - 7:26AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/9nmxfv/pyelonephritis)
has announced the addition of the "Pyelonephritis - Pipeline
Review, H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Pyelonephritis, complete with
comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in
the therapeutic development for Pyelonephritis and special features
on late-stage and discontinued projects.
The report enhances decision making capabilities and helps to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Companies Mentioned
Achaogen Inc.
AstraZeneca Plc
Merck & Co., Inc.
MerLion Pharmaceuticals Pte Ltd
The Medicines Company
For more information visit
http://www.researchandmarkets.com/research/9nmxfv/pyelonephritis
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150904005290/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Infectious Diseases